Skip to content

Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic Control

Tight Glycemic Control and Sepsis Related Dyslipidemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01013662
Enrollment
69
Registered
2009-11-16
Start date
2005-01-31
Completion date
2007-07-31
Last updated
2011-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Septic Shock

Keywords

septic shock, glycemic control, icu, lipid metabolism, septic patients

Brief summary

Study of the lipid metabolism under glycemic control in septic patients who got an university 14 bed ICU. Hypothesis: establish a relationship between lipid metabolism alterations and glycemic control or infusion of exogenous insulin

Detailed description

The investigators enrolled 69 consecutive patients with severe sepsis or septic shock and divided them in two different groups after randomization with sealed envelopes. One group called intensive glycemic control with glycemic levels been between 80 to 110 mg/dl with exogenous insulin. The other group called conventional glycemic control with glycemic levels been between 180 and 220 mg/dl. Blood samples were collected at 0, 12, 24, 48 and 72 hours to measure HDL, LDL, Total cholesterol, free fatty acids and oxidized LDL. Clinical data as creatinine, P/F ratio, bilirubins, platelets, lactate, arterial blood gasometry were either monitored.

Interventions

PROCEDUREglycemic control

exogenous insulin

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* all patients aged between 18 and 80 years old * with the diagnostic of septic shock or severe sepsis

Exclusion criteria

* pregnants, * previous diagnosis of any cancer, * diagnosis of leptospirosis, * diagnosis of aids.

Design outcomes

Primary

MeasureTime frame
establish a relationship between lipid metabolism alterations and glycemic control2 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026